Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes

Kidney International

Volumn 54, Issue 2, 1998, Pages 570-579

  Pertosa, Giovanni ^a   Grandaliano, Giuseppe ^a   Gesualdo, Loreto ^a   Ranieri, Elena ^a   Monno, Raffaella ^a   Schena, F Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Cuprophan; Cytokines; High flux dialysis; Immune system; PBMC dysfunction; Polyamide; Polymethylmethacrylate; Uremia

Indexed keywords

CUPROPHANE; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; POLY(METHYL METHACRYLATE); POLYAMIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; GENE EXPRESSION; HEMODIALYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; UREMIA;

EID: 0031871080     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00020.x     Document Type: Article

References (35)

1. CHATENOUD L, HERBELIN A, BEAURAIN G, DESCHAMPS-LATSCHA B: Immune deficiency of the uremic patients. Adv Nephrol 19:259-274, 1990
2. MORRISON AB, MANESS K, TAWES R: Skin homograft survival in chronic renal insufficiency. Arch Pathol 75:139-143, 1963
3. GOLDBLUM SE, REED WP: Immunological alterations in chronic renal failure. Ann Intern Med 93:597-613, 1980
4. STEVENS CE, ALTER HJ, TAYLOR DE, ZANG EA, HARLEY EJ, ZMUENS W, THE DIALYSIS VACCINE TRIAL STUDY GROUP: Hepatitis B vaccine in patients receiving hemodialysis. N Engl J Med 311:496-501, 1984
5. HAY WE, CESTERO RV, FREEMAN RB: Deficiency of T and B lymphocytes in uremic subjects and partial improvement with maintainance hemodialysis. Nephron 20:182-188, 1978
6. LEWIS SL, VAN BEERS D: Neutrophils and monocytes alterations in chronic dialysis patients. Am J Kidney Dis 9:2381-2386, 1986
7. ZAOUI P, STONE WJ, HAKIM RM: Natural killer-cell function in hemodialysis patients: Effect of dialysis membrane. Kidney Int 43: 1298-1305, 1993
8. HAAG-WEBER M, SCHOLLMEYER P, HORL WH: Neutrophil activation during hemodialysis. Av Exp Med Biol 260:191-198, 1989
9. VANHOLDER R, RINGOIR S: Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review. J Am Soc Nephrol 3:1541-1554, 1993
10. LINDNER A, FAREWELL VT, SHERRAD DJ: High incidence of neoplasia in uremic patients receiving long-term dialysis. Nephron 27:292-296, 1981
11. SCHINDLER R, LONNEMANN G, SHALDON S, KOCH KM, DINARELLO CA: Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37:85-93, 1990
12. LUGER A, KOVARIC J, STUMMIVOLL H-K, URBANSKA A, LUGER TA: Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32:84-88, 1987
13. PERTOSA G, GESUALDO L, BOTTALICO D, SCHENA FP: Endotoxins modulate chronically tumour necrosis factor α and interleukin 6 release by uraemic monocytes. Nephrol Dial Transplant 10:328-333, 1995
14. DINARELLO CA: Agents provocateurs in hemodialysis? Kidney Int 41:683-694, 1992
15. ZAOUI P, HAKIM RM: The effect of the dialysis membrane on cytokine release. J Am Soc Nephrol 4:1711-1718, 1994
16. HERBELIN A, URENA P, NGUYEN AT, ZINGRAFF J, DESCAMPS-LATSCHA B: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 39:954-960, 1991
17. AKAHOSHI T, KOBAYASHI N, HOSAKA S, SEKIYAMA N, WADA C, KONDO H: In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. Nephrol Dial Transplant 10:2244-2249, 1995
18. NAKANISHI I, MOUTABARRIK A, OKADA N: Interleukin-8 in chronic renal failure and dialysis patients. Nephrol Dial Transplant 9:1435-1442, 1994
19. PEREIRA BJG, POUTSIAKA DD, KINO AJ: In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int 42:1419-1424, 1992
20. LONNEMANN G, BARNDT I, KAEVER V, HAUBITZ M, SCHINDLER R, SHALDON S, KOCH KM: Impaired endotoxin-induced interleukin-1β secretion, not total production, of mononuclear cells from ESRD patients. Kidney Int 47:1158-1167, 1995
21. FREIDLANDER MA, HILBERT CM, WU YC, RICH EA: Role of dialysis modality in responses of blood monocytes and peritoneal macrophages to endotoxin stimulation. Am J Kidney Dis 22:11-23, 1993
22. KINO K, AKIZAWA T, KOSHIKAWA S: Effects of membrane characteristics on cytokine production by mononuclear cells in regular haemodialysis patients. Nephrol Dial Transplant 10(Suppl 3):29-33, 1995
23. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
24. GESUALDO L, DI PAOLO S, MILANI S, PINZANI M, RANIERI E, GRAPPONI C, SCHENA FP: Expression of platelet-derived growth factor receptors in normal and diseased human kidney. J Clin Invest 94:50-58, 1994
25. SHALDON S, LONNEMANN G, KOCH KM: Cytokine relevance in biocompatibility. Contrib Nephrol 79:227-236, 1987
26. LONNEMANN G, VAN DER MEER JWM, CANNON JG: Induction of tumor necrosis factor during extracorporeal blood purification. N Engl J Med 317:963-964, 1987
27. HERBELIN A, URENA P, NGUYEN AT, ZINGRAFF J, DESCAMPS-LATSCHA B: Influence of first and long-term dialysis on uremic-associated increased basal production of interleukin-1 and tumor necrosis factor-α by circulating monocytes. Nephrol Dial Transplant 6:349-357, 1991
28. MEMOLI B, LIBETTA C, RAMPINO T: Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 42:320-326, 1992
29. PACZEK L, SCHAEFER RM, HEIDLAND A: Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro. Nephrol Dial Transplant S3:41-44, 1991
30. KISHIMOTO T: The biology of interleukin 6. Blood 74:1-10, 1989
31. LEONARD EJ, YOSHIMURA T: Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11:97-101, 1993
32. BAGGIOLINI M, WALZ A, KUNKEL SL: Neutrophil activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1047, 1989
33. CHATENOUD L, JUNGERS P, DESCHAMPS-LATSCHA B: Immunological considerations of the uremic and dialyzed patient. Kidney Int 45(Suppl 44):S92-S96, 1994
34. DESCHAMPS-LATSCHA B, HERBELIN A, NGUYEN AT: Balance between IL-1β, TNF-α and their specific inhibitors in chronic renal failure and maintenance dialysis: Relationship with activation markers of T cells, B cells and monocytes. J Immunol 154:882-892, 1995
35. MAEDA T, YAMAGUCHI M, TAGA T, KISHIMOTO T, WADA K, IKEGAMI H, KURACHI H, MIYAKE A: Decidua is a possible source of serum mouse soluble interleukin-6 receptor (msIL-6R): Gestational profile of serum msIL-6R concentration. Biochem Biophys Res Commun 205:998-1003, 1994